Novocuff, Inc., has successfully closed an oversubscribed $26 million Series A funding round to advance their mission of improving pregnancy outcomes and reducing the incidence of preterm births. This significant financial milestone follows an initial seed round of $2 million. AXA IM Alts, a leader in global healthcare investments, spearheaded the funding with a substantial […]
In a major move set to transform the landscape of critical care innovation in India, Tata Elxsi and Dräger, a global leader in medical and safety technology, have embarked on a strategic collaboration. Central to this partnership is the establishment of a new Offshore Development Center (ODC) at Tata Elxsi’s Pune facility, poised to develop […]
Olympus Corporation, a Japan-based medtech company, will acquire Taewoong Medical Co., a South Korea-based gastrointestinal stents manufacturer, for up to $370 million (approximately KRW 482 billion) in cash. Under the agreement, Olympus will pay $255.5 million at the closing of the transaction and will make milestone payment of up to $114.5 million. With the proposed […]
Shalby Limited, an Indian multi-specialty hospital chain, has acquired certain implant assets from Consensus Orthopedics, a California-based medical equipment manufacturer, for $11.45 million in cash. The assets were purchased by Shalby Advanced Technologies, a fully-owned subsidiary of Mars Medical Devices, which in turn is a 100% subsidiary of Shalby. Consensus Orthopedics is engaged in designing […]
US healthcare company Cardinal Health has agreed to divest its Cordis medical devices business to private equity company Hellman & Friedman (H&F) for about $1 billion. Hellman & Friedman is being partnered by Ajax Health, a venture capital company, and Zeus Health, a KKR-backed medical device platform, in the transaction. Cordis is engaged in the […]
Boston Scientific has announced that its LUMINIZE Radiofrequency (RF) Balloon Catheter, developed for isolating pulmonary veins (PVs) in atrial fibrillation (AF) treatment, has demonstrated positive safety and efficacy results in the AF-FICIENT I clinical trial. This new device marks an advancement in cardiac ablation technology and its ability to enhance treatment outcomes for patients with […]
The US Food and Drug Administration (FDA) has approved the Cobra PzF nanocoated coronary stent system developed by Texas medical device maker CeloNova BioSciences.
The US Food and Drug Administration (FDA) has approved the Cobra PzF nanocoated coronary stent system developed by Texas medical device maker CeloNova BioSciences. Approval of the nanocoated Cobra PzF coronary stent system from the regulator comes on the backdrop of the PzF Shield clinical trial whose primary safety and effectiveness endpoints were met in […]